Sign In
Buy PGEN
$6.27
+0.330 (+5.56%)
At Close: Jul 31, 2026
Here's Why Precigen, Inc. (PGEN) Is a Great 'Buy the Bottom' Stock Now
11:26am, Tuesday, 14'th Mar 2023
Precigen, Inc. (PGEN) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among
5 Penny Stocks To Buy According To Analysts, Targets Up To 952%
04:35pm, Tuesday, 07'th Mar 2023 PennyStocks
Penny stocks to buy according to analysts in 2023
The post 5 Penny Stocks To Buy According To Analysts, Targets Up To 952% appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
5 Penny Stocks To Buy According To Analysts, Targets Up To 952%
11:35am, Tuesday, 07'th Mar 2023
Penny stocks to buy according to analysts in 2023 The post 5 Penny Stocks To Buy According To Analysts, Targets Up To 952% appeared first on Penny Stocks to Buy, Picks, News and Information | PennySto
Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates
10:15pm, Tuesday, 28'th Feb 2023 Zacks Investment Research
Fate Therapeutics (FATE) delivered earnings and revenue surprises of 32.56% and 124.91%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
3 Penny Stocks The Insiders Are Buying
06:01am, Tuesday, 28'th Feb 2023
Penny stocks come with many risks, but with those risks come the potential for great rewards. While there is no guarantee which penny stocks will deliver those rewards, following the insiders is 1 way
BioMarin Pharmaceutical (BMRN) Q4 Earnings Lag Estimates
10:35pm, Monday, 27'th Feb 2023 Zacks Investment Research
BioMarin (BMRN) delivered earnings and revenue surprises of -7.69% and 0.69%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Ultragenyx (RARE) Reports Q4 Loss, Tops Revenue Estimates
10:15pm, Thursday, 16'th Feb 2023 Zacks Investment Research
Ultragenyx (RARE) delivered earnings and revenue surprises of -6.40% and 0.27%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week
06:49pm, Thursday, 16'th Feb 2023 The Motley Fool
Concerns about a tough financing environment weighed on clinical-stage biotech stocks this week.
Why Altimmune, Foghorn Therapeutics, and Precigen Shares Crashed This Week
01:49pm, Thursday, 16'th Feb 2023
Concerns about a tough financing environment weighed on clinical-stage biotech stocks this week.
3 Penny Stocks To Buy According To Insider Bets Up To $25 Million
08:53pm, Monday, 06'th Feb 2023 PennyStocks
Penny stocks to buy according to insider trades this quarter.
The post 3 Penny Stocks To Buy According To Insider Bets Up To $25 Million appeared first on Penny Stocks to Buy, Picks, News and Informat
3 Penny Stocks To Buy According To Insider Bets Up To $25 Million
03:53pm, Monday, 06'th Feb 2023
Penny stocks to buy according to insider trades this quarter. The post 3 Penny Stocks To Buy According To Insider Bets Up To $25 Million appeared first on Penny Stocks to Buy, Picks, News and Informat
$20 Million Bet On Precigen? Check Out These 4 Penny Stocks Insiders Are Buying
03:44pm, Wednesday, 01'st Feb 2023 Benzinga
The Dow Jones jumped more than 350 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested i
Precigen, Inc. (PGEN) Moves to Buy: Rationale Behind the Upgrade
05:00pm, Friday, 27'th Jan 2023 Zacks Investment Research
Precigen, Inc. (PGEN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Precigen, Inc. (PGEN) Moves to Buy: Rationale Behind the Upgrade
01:33pm, Friday, 27'th Jan 2023
Precigen, Inc. (PGEN) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring, But Not Yet Talking About
08:56pm, Thursday, 26'th Jan 2023 Benzinga
Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. Retail traders have countless methods at their disposal to uncover new information. For some, this
